CD8A and cancer: Notably, among the 22 immune cells, the correlation matrix portrayed that RRM2 expression had a negative association with CD8+ T cells in various cancers, including AA, BRCA, ESCA, LAML, PAAD, PRAD, SKCM and THCA (Figure 7A).